Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.58312 | 24 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.56186 | 24 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.56445 | 24 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.52759 | 25 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.48374 | 23 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.59879 | 23 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.56044 | 22 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.54578 | 24 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.54377 | 24 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.55863 | 25 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.54373 | 24 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.54639 | 25 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.56102 | 24 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.55267 | 24 |